Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Female Contraception Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Female Contraception Drugmarket, defines the market attractiveness level of Female Contraception Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Female Contraception Drug industry, describes the types of Female Contraception Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Female Contraception Drug market and the development prospects and opportunities of Female Contraception Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Female Contraception Drug market in Chapter 13.
By Player:
Evofem Inc
Bayer AG
Hervana Ltd
Viramal Ltd
Addex Therapeutics Ltd
Agile Therapeutics Inc
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
By Type:
AG-890
Amphora
BAY-1007626
Drospirenone
Others
By End-User:
Clinic
Hospital
Homecare
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Female Contraception Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Female Contraception Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Female Contraception Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Female Contraception Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Female Contraception Drug Market Analysis and Outlook to 2022
-
7.1 Global Female Contraception Drug Consumption (2017-2022)
-
7.2 United States Female Contraception Drug Consumption (2017-2022)
-
7.3 Europe Female Contraception Drug Consumption (2017-2022)
-
7.4 China Female Contraception Drug Consumption (2017-2022)
-
7.5 Japan Female Contraception Drug Consumption (2017-2022)
-
7.6 India Female Contraception Drug Consumption (2017-2022)
-
7.7 South Korea Female Contraception Drug Consumption (2017-2022)
8 Region and Country-wise Female Contraception Drug Market Analysis and Outlook to 2028
-
8.1 Global Female Contraception Drug Consumption Forecast (2022-2028)
-
8.2 United States Female Contraception Drug Consumption Forecast (2022-2028)
-
8.3 Europe Female Contraception Drug Consumption Forecast (2022-2028)
-
8.4 China Female Contraception Drug Consumption Forecast (2022-2028)
-
8.5 Japan Female Contraception Drug Consumption Forecast (2022-2028)
-
8.6 India Female Contraception Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Female Contraception Drug Consumption Forecast (2022-2028)
9 Global Female Contraception Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Female Contraception Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AG-890 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Amphora Consumption and Growth Rate (2017-2022)
-
9.1.3 Global BAY-1007626 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Drospirenone Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Female Contraception Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Homecare Consumption and Growth Rate (2017-2022)
10 Global Female Contraception Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Female Contraception Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AG-890 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Amphora Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global BAY-1007626 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Drospirenone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Female Contraception Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Homecare Consumption Forecast and Growth Rate (2022-2028)
11 Global Female Contraception Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Female Contraception Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Female Contraception Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Female Contraception Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Female Contraception Drug Market Competitive Analysis
-
14.1 Evofem Inc
-
14.1.1 Evofem Inc Company Details
-
14.1.2 Evofem Inc Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Evofem Inc Female Contraception Drug Product and Service
-
14.2 Bayer AG
-
14.2.1 Bayer AG Company Details
-
14.2.2 Bayer AG Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer AG Female Contraception Drug Product and Service
-
14.3 Hervana Ltd
-
14.3.1 Hervana Ltd Company Details
-
14.3.2 Hervana Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Hervana Ltd Female Contraception Drug Product and Service
-
14.4 Viramal Ltd
-
14.4.1 Viramal Ltd Company Details
-
14.4.2 Viramal Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Viramal Ltd Female Contraception Drug Product and Service
-
14.5 Addex Therapeutics Ltd
-
14.5.1 Addex Therapeutics Ltd Company Details
-
14.5.2 Addex Therapeutics Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Addex Therapeutics Ltd Female Contraception Drug Product and Service
-
14.6 Agile Therapeutics Inc
-
14.6.1 Agile Therapeutics Inc Company Details
-
14.6.2 Agile Therapeutics Inc Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Agile Therapeutics Inc Female Contraception Drug Product and Service
-
14.7 Mithra Pharmaceuticals SA
-
14.7.1 Mithra Pharmaceuticals SA Company Details
-
14.7.2 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Mithra Pharmaceuticals SA Female Contraception Drug Product and Service
-
14.8 Orbis Biosciences Inc
-
14.8.1 Orbis Biosciences Inc Company Details
-
14.8.2 Orbis Biosciences Inc Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Orbis Biosciences Inc Female Contraception Drug Product and Service
-
14.9 Teva Pharmaceutical Industries Ltd
-
14.9.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.9.2 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Female Contraception Drug
-
Figure Female Contraception Drug Picture
-
Table Global Female Contraception Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Female Contraception Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Female Contraception Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Female Contraception Drug Consumption by Country (2017-2022)
-
Figure United States Female Contraception Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Female Contraception Drug Consumption and Growth Rate (2017-2022)
-
Figure China Female Contraception Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Female Contraception Drug Consumption and Growth Rate (2017-2022)
-
Figure India Female Contraception Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Female Contraception Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Female Contraception Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Female Contraception Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Female Contraception Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Female Contraception Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Female Contraception Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Female Contraception Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Female Contraception Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AG-890 Consumption and Growth Rate (2017-2022)
-
Figure Global Amphora Consumption and Growth Rate (2017-2022)
-
Figure Global BAY-1007626 Consumption and Growth Rate (2017-2022)
-
Figure Global Drospirenone Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Homecare Consumption and Growth Rate (2017-2022)
-
Figure Global AG-890 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amphora Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BAY-1007626 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drospirenone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Female Contraception Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Female Contraception Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Evofem Inc (Foundation Year, Company Profile and etc.)
-
Table Evofem Inc Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Evofem Inc Female Contraception Drug Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Female Contraception Drug Product and Service
-
Table Hervana Ltd (Foundation Year, Company Profile and etc.)
-
Table Hervana Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hervana Ltd Female Contraception Drug Product and Service
-
Table Viramal Ltd (Foundation Year, Company Profile and etc.)
-
Table Viramal Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viramal Ltd Female Contraception Drug Product and Service
-
Table Addex Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table Addex Therapeutics Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Addex Therapeutics Ltd Female Contraception Drug Product and Service
-
Table Agile Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Agile Therapeutics Inc Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agile Therapeutics Inc Female Contraception Drug Product and Service
-
Table Mithra Pharmaceuticals SA (Foundation Year, Company Profile and etc.)
-
Table Mithra Pharmaceuticals SA Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mithra Pharmaceuticals SA Female Contraception Drug Product and Service
-
Table Orbis Biosciences Inc (Foundation Year, Company Profile and etc.)
-
Table Orbis Biosciences Inc Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orbis Biosciences Inc Female Contraception Drug Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Product and Service
-
